patent.fyi
Applications  /  US 2026/0354704
United States Patent Application Publication

US 2026/0354704 A1

Published
Nov 12, 2026
Filed
Jul 7, 2026
Earliest date on the face
Mar 28, 2024
Classification
A61B 5/0537
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Reference patch on opposite forearm

What ifWhat if the reference patch sits on the opposite forearm?
Claim language“on skin of a patient's chest”

The forearm electrodes measure impedance at the same frequencies as the infusion-site electrodes. The analysis unit compares the change from each site's preinfusion baseline and uses the opposite forearm to track changes across both sites.

1.2Two electrodes with interface correction

What ifWhat if two electrodes handle both the broadband measurement and ECG sensing?
Claim language“at least four electrodes”

The same two hydrogel electrodes deliver the stimulus and sense the resulting voltage. The processor fits a frequency-dependent electrode interface model to the measured spectrum to estimate tissue impedance. A differential amplifier samples ECG from the same contacts between stimulus bursts.

1.3Chest motion from belt stretch

What ifWhat if a stretch sensor in an elastic chest band measures chest wall motion?
Claim language“at least one accelerometer”

A piezoresistive strip changes resistance as the band stretches during inspiration. A bridge circuit digitizes the resistance waveform, and a calibration curve maps that waveform to changes in chest circumference.

1.4Sequential single-frequency chest measurements

What ifWhat if the chest electronics apply one frequency at a time?
Claim language“simultaneously at a plurality of frequencies”

A programmable oscillator steps through a frequency table while an adjustable current source drives the chest electrodes. At each step, synchronous detection measures voltage amplitude and phase, and the processor assembles the individual readings into an impedance spectrum.

1.5Infusion-site sensor in a cuff

What ifWhat if a hinged cuff carries the infusion-site electrodes?
Claim language“a second patch”

Spring-backed electrode holders in the cuff press four conductive contacts against the skin around the infusion site. An opening in the cuff provides clearance for the catheter and dressing, and electronics in the cuff drive one electrode pair and sense voltage across the other.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Infusion monitoring in veterinary care

A four-electrode patch with an accelerometer sits on a clipped area of the thorax of a dog receiving intravenous fluids, and a second four-electrode patch sits beside a forelimb catheter. Two electrodes on the thoracic patch also record cardiac electrical activity. Each patch applies a simultaneous set of excitation frequencies and transmits the measured tissue response to a bedside unit. The unit calculates changes from pre-infusion fluid estimates at both sites and alerts staff when the local change exceeds the thoracic change by a configured amount.

Component substitution

Carbon silicone dry contact electrodes

Four molded carbon-loaded silicone contacts on each patch replace gel contacts and sit in openings in a flexible insulating backing. An adhesive perimeter holds the contacts against the skin, and individual conductive traces connect them to the patch electronics. A current driver applies the simultaneous excitation tones through the outer pair, and a differential amplifier records the response across the inner pair. On the chest patch, a low-pass input stage also routes the signal from the inner pair to a cardiac recording channel.

Parameter or scale variation

Six electrode patch with selectable spacing

The infusion-site patch carries six contacts in a straight line at 5 mm center-to-center spacing, with the line placed alongside the catheter site. The electronics alternate between driving the outermost pair at 25 mm separation and driving the next pair inward at 15 mm separation, while sensing across the central pair. Each configuration applies eight simultaneous frequencies between 10 kHz and 1 MHz and records a 100 ms response window. The analysis unit compares the baseline-normalized response for each spacing with the concurrent thoracic measurement and displays the two local trends separately.

Combination with existing systems

Integration with infusion pump telemetry

The two patches send their tissue responses to a bedside analysis unit that also receives infusion state, flow rate, and delivered volume from a networked infusion pump. The unit timestamps both data streams on a common clock and calculates a baseline from patch measurements collected before pump start. During infusion, the display aligns the local and thoracic fluid trends with pump start, rate changes, and delivered volume. When the local fluid estimate exceeds the thoracic reference by the configured threshold, the unit records the alert with the pump channel and delivered volume at that time.

Automated or data-driven variant

Motion gated infusion site measurements

A three-axis accelerometer on the infusion-site patch records limb motion on the same clock as the broadband tissue measurements. The analysis unit calculates acceleration variability for each measurement window and marks the window unusable when variability exceeds a configured threshold. The software updates the local fluid trend from usable windows and compares it with contemporaneous thoracic readings. A separate display indicator appears when a configured interval elapses without a usable local reading.

Detection of sustained local fluid increases

The bedside unit records paired thoracic and infusion-site fluid estimates during a pre-infusion interval and uses their difference to compute a baseline mean and variability. During infusion, the software subtracts the baseline mean from each new difference and scales the result using the baseline variability and a configured minimum variability. A one-sided cumulative sum adds each scaled result after subtracting a configured allowance and resets to zero whenever the sum becomes negative. The display issues a local fluid trend alert when the sum crosses a configured limit.

Specific version of a part

Printed hydrogel chest electrodes

Four printed silver–silver chloride contacts sit in a row on a flexible polyurethane backing. The outer pair injects current, and the inner pair senses tissue voltage through conductive hydrogel. A separate filtered amplifier records ECG from the inner pair during pauses in the stimulus.

Three-axis chest motion sensor

A three-axis capacitive microelectromechanical accelerometer mounts on the chest patch and samples at 100 samples per second. The processor projects the acceleration onto the axis normal to the patch and filters the resulting signal to retain the respiratory motion band.

Four-contact infusion-site array

Four hydrogel contacts form a line along the infusion limb, with the voltage-sensing pair centered beside the catheter entry point and the current-driving pair outside it. The electronics apply a combined 50 kHz, 250 kHz, 1 MHz and 5 MHz stimulus, then measure the amplitude and phase of each tone in the same sampling window.

Bedside fluid comparison display

Two radio receivers deliver time-stamped chest and infusion-site spectra to a bedside processor once per second. The processor fits each spectrum to a tissue impedance model to estimate mean and local tissue fluid volumes. The display shows both estimates in milliliters and raises a visual alert when the local estimate exceeds the mean by the configured threshold.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2013/0274615 A1
Published
Oct 17, 2013
Filed
Apr 12, 2013
Class
A61B 5/0205
Document BUS 9,848,826 B2
Published
Dec 26, 2017
Filed
Feb 25, 2015
Class
A61B 5/7221
Claim 1
Document A
Document B
1.1a first patch configured to be disposed non-invasively on skin of a patient's chest;
In IPG measurement of ICP, electrodes placed externally on the scalp, neck, and/or chest may be used to drive current into the patient and measure the induced voltage.
A · US 2013/0274615 A1 · ¶ 30
One embodiment includes at least one sensing electrode 135, one therapy electrode 140 disposed in front of the subject, e.g., proximate to the subject's chest, and two therapy electrodes 140 disposed in back of the subject, e.g. proximate to the subject's back.
B · US 9,848,826 B2 · ¶ 34
1.2a first set of at least four electrodes disposed on the first patch configured to contact the skin to perform broadband tissue response measurements, wherein two of the at least four electrodes also are configured to sense an ECG signal from the patient;
Each sensor section 150 may include one pair of front electrodes, front current electrode 111 and front voltage electrode 112, and one pair of rear electrodes, rear current electrode 114, and rear voltage electrode 113.
A · US 2013/0274615 A1 · ¶ 48
For example, sensing electrode 135 can include electrocardiogram electrodes that directly or indirectly (e.g., via clothes, a conductive protective barrier, or a conductive fluid) contact the subject's skin to sense an electrocardiogram signal with minimal artifacts.
B · US 9,848,826 B2 · ¶ 36
1.3at least one accelerometer disposed on the first patch configured to be coupled to the skin to measure chest wall motion of the patient;
1.4a first electronics unit disposed on the first patch having a first communications module, the first electronics unit configured to apply an electrical stimulus simultaneously at a plurality of frequencies up to and including about 5.0 MHz through respective pairs of the first set of at least four electrodes to generate a first composite response corresponding to a first plurality of responses simultaneously measured at each of the plurality of frequencies;
To obtain more than one IPG measurement, for example by measuring simultaneously both right and left IPG signals, an alternating current frequency used in each of the measurements may be different, to differentiate between the sides. Using this technique, the voltage signal obtained from each side may be demodulated with respect to the corresponding current or with respect to the current delivered in the opposite side.
A · US 2013/0274615 A1 · ¶ 62
1.5a second patch configured to be disposed non-invasively on the skin of a patient near an infusion site;
1.6a second set of at least four electrodes disposed on the second patch configured to contact the skin of a patient near the infusion site to perform broadband tissue response measurements; a second electronics unit disposed on the second patch having a second communications module, the second electronics unit configured to apply an electrical stimulus simultaneously at a plurality of frequencies up to an including about 5.0 MHz through respective pairs of the second set of at least four electrodes to generate a second composite response corresponding to a second plurality of responses simultaneously measured at each of the plurality of frequencies; and
To obtain more than one IPG measurement, for example by measuring simultaneously both right and left IPG signals, an alternating current frequency used in each of the measurements may be different, to differentiate between the sides. Using this technique, the voltage signal obtained from each side may be demodulated with respect to the corresponding current or with respect to the current delivered in the opposite side.
A · US 2013/0274615 A1 · ¶ 62
1.7an external analysis unit having an associated display screen, the external analysis unit configured to receive the first and second composite responses via the first and second communications modules, to compute and compare mean and local tissue fluid volumes responsive to the first and second composite responses, and to present on the display screen an alert if the local tissue fluid volume exceeds the mean tissue fluid volume by a threshold amount.
For example, sensing electrode 135 can sense electrical activity of the subject's heart signals, and controller 130 can provide these signals for display as an electrocardiograph on monitor 125. When an arrhythmic event or other form of cardiac distress is detected, controller 130 can instruct alarm module 120 to provide a warning that the subject wearing wearable therapeutic device 100 is in danger of, or is experiencing, for example, cardiac arrest.
B · US 9,848,826 B2 · ¶ 37

An empty cell means only that no passage was reproduced there.

Statements in these documents
In some instances, the lack of continuous monitoring, the cost of these machines, their limited mobility, and/or their significant expense per use, may limit their usefulness in situations where either regular, continuous, or frequent monitoring of intracranial physiological characteristics may be desirable.
A · US 2013/0274615 A1 · ¶ 5
In some embodiments, these methods and systems may be useful, for example, for continuous or frequent use and may involve, for example, electrodes, and/or a patient headset and cerebral perfusion monitor for acquiring impedance signals and extracting waveforms for estimating ICP and additional intracranial physiological parameters.
A · US 2013/0274615 A1 · ¶ 7
These efforts are expensive and have a limited success rate, and cardiac arrest, among other conditions, continues to claim the lives of victims.
B · US 9,848,826 B2 · ¶ 5
Based at least in part on changes in the inductance or the capacitance as the wearable therapeutic device changes shape, the wearable therapeutic device can provide notifications to the subject regarding arrhythmias, cardiac events, the condition of the wearable therapeutic device, and the positioning of electrodes or other wearable therapeutic device components relative to the subject.
B · US 9,848,826 B2 · ¶ 6
Cite aspatent.fyi, US 2026/0354704 A1, claim 1, first published 2026-11-19T02:47:19-05:00, https://patent.fyi/US20260354704/, SHA-256 e93910b2db229d7fd7e7b7aae56b8e9420b979d97ff833a51099b3f261c2c502
First published
Permanent addresshttps://patent.fyi/US20260354704/
Content fingerprint (SHA-256)e93910b2db229d7fd7e7b7aae56b8e9420b979d97ff833a51099b3f261c2c502
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi